Minapharm Pharmaceuticals

Last Updated:
  • 251.52 EGP
  • -2.79
  • -1.10%
مينا فارم للأدوية والصناعات الكيماوية
مينا فارم للأدوية
Symbol : MIPH
ISIN : EGS380G1C011
Day Range : -
Turnover Ratio : 0.08
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Latest Announcements
2025-09-10 06:15:00.0العنوان : مينا فارم للأدوية والصناعات الكيماوية (MIPH.CA) محضر إجتماع الجمعية العامة العادية التى انعقدت فى 2025/09/09 (غير موثق) اسم الشركة : مين
2025-08-21 06:30:00.0العنوان : مينا فارم للأدوية والصناعات الكيماوية (MIPH.CA) القوائم المالية المستقلةاسم الشركة : مينا فارم للأدوية والصناعات الكيماويةكود التر
2025-08-21 06:29:00.0Minapharm Pharmaceuticals (MIPH.CA) - Board of Directors' Meeting Minutes
2025-08-20 08:35:00.0تم ايقاف الورقة المالية - EGS380G1C011 - مينا فارم للأدوية و الصناعات الكيماوية لمدة 10 دقائق لتجاوزها نسبة 10 %
2025-08-19 12:02:00.0Release from Minapharm Pharmaceuticals (MIPH.CA) Regarding the Financial Statements

Minapharm Pharmaceuticals Stock Overview

View Company Profile

Stock Summary

Last Price (EGP) 251.52
Prev. Close 254.310
Day Range 250.00 - 259.99
52WK range
Turnover (M EGP) 0.52
Volume (M) 0.00
Number of Trades 66
Market Cap (M EGP) 3,126.34
Change in Market Cap (M EGP)
VWAP (EGP) 251.56
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M EGP)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
16-Nov-2025 Distribution of cash dividends

Cairo - Mubasher: The Egyptian Exchange (EGX) on Monday announced the acquisition of 6.36 million shares in Minapharm Pharmaceuticals in a block-trading...

Cairo - Mubasher: The shareholders of Minapharm Pharmaceuticals greenlighted a cash dividend distribution worth EGP 2.80 per share for 2022.The general...

Cairo - Mubasher: The board of Minapharm Pharmaceuticals agreed to increase the company’s issued capital by EGP 602.98 million through bonus shares,...

Mubasher: Dubai-based Bioventure, Minapharm Pharmaceuticals, and MiGenTra GmbH have signed an exclusive licence agreement for the commercialisation of...

Cairo – Mubasher: Minapharm Pharmaceuticals' consolidated net profits jumped by 75.1% to EGP 352.36 million in the first nine...